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Introduction
Measles vaccination made an important contribution to the 
millennium development goal to reduce under-5 mortality 
(MDG4),1 accounting for 23% of the estimated worldwide 
decline in all-cause child mortality from 1990 to 2008.2,3 A 
cornerstone of the strategy was that all children be offered a 
second opportunity to receive a dose of measles-containing 
vaccine, either through routine immunization services or 
through mass vaccination campaigns (known as supplemen-
tary immunization activities).4 Supplemental immunization 
targets all children, to reach those who have been missed by 
routine services and also those who may have failed to develop 
an appropriate immune response after vaccination.4 The strat-
egy has been widely implemented in sub-Saharan Africa over 
the last decade, with measurable success in reducing mortality.5 
India delayed implementing supplementary immunization, 
and this may have contributed to the slower decline in measles 
mortality as compared with sub-Saharan Africa. India’s share 
of global measles mortality increased from 16% of 535 300 
deaths (95% confidence interval, CI: 347 200–976 400) in 2000 
to 47% of 139 300 deaths (95% CI: 71 200–447 800) in 2010.6
In 2010, India introduced a second opportunity to receive 
measles-containing vaccine through routine immunization 
programmes in states with 80% or higher coverage of the first 
dose of measles-containing vaccine, and elsewhere through 
supplementary immunization activities. India’s first supple-
mentary mass measles vaccination campaign took place from 
2010 to 2013 in 14 states7 containing 59% of India’s 113 million 
under-5 children (authors’ calculations based on census data).8 
These 14 states have relatively weak health systems compared 
with the national average9 and poorer progress towards 
MDG4.10 The supplementary immunization activity reached 
119 million children aged nine months to 10 years, achiev-
ing 91% coverage of the target population of 130 743 905.11 
India’s first round of supplementary mass measles vaccination 
delivered only a measles-containing vaccine dose. Planning is 
underway for a larger measles–rubella vaccine introduction 
campaign targeting children aged 1–15 years.12
Campaign-style delivery has two key advantages over rou-
tine services; it can achieve high coverage even in areas where 
the reach of routine services is weak2 and it reduces access 
barriers. On the other hand, a weakness of campaign delivery 
is that it represents a one-time or cyclic event. Some countries 
have made strategic use of mass vaccination campaigns to 
offer additional health interventions such as vitamin A supple-
ments, insecticide-treated bednets and deworming medicines.2 
Therefore, vaccination campaigns could serve as an important 
platform to extend the reach of health services to underserved 
groups and improve maternal and child survival.
To date, India has largely not included add-on interven-
tions with its mass vaccination campaigns and Indian health 
planners have expressed concerns over the potential challenges 
of implementing these, while agreeing that add-ons could be 
beneficial in principle.9 To inform the design of future supple-
mentary immunization activities in India and elsewhere we 
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aimed to project the impact on mortal-
ity of a hypothetical set of technically 
feasible, high-impact interventions for 
maternal and child survival, delivered 
during India’s 2010–2013 mass measles 
vaccination campaign.
Methods
For states participating in the supple-
mentary immunization activity, we 
conducted a mathematical modelling 
study to quantify: (i) the number of lives 
saved by a supplementary immunization 
activity delivering measles-containing 
vaccine alone, and (ii) the number of 
lives that could be saved by a supple-
mentary immunization activity package 
delivering measles-containing vaccine 
plus a set of six hypothetical add-on 
interventions. The analysis baseline 
reflected existing coverage levels for all 
interventions offered through routine 
services. Within each state we also as-
sessed the impact of the interventions 
on mortality by child’s sex. Ethics ap-
proval was not required for this study 
as it used only secondary data with 
no personal identifiable information. 
A technical appendix containing full 
details of the methods is available from 
the corresponding author.
Selection of interventions
We selected add-on interventions for 
modelling through a literature review 
and expert consultation. First, we used 
two systematic reviews to identify ma-
ternal and child health interventions 
that had been linked to routine im-
munization or vaccination campaigns 
(but not specific to measles) in a low- 
or middle-income country, identified 
from two systematic reviews.13,14 Then 
we updated the literature search from 
these reviews to 15 May 2015, and 
consulted supplementary sources.2,15–17 
Further suggestions were contributed 
by programme experts, including ad-
ministrators and managers involved 
in India’s 2010–2013 measles supple-
mentary immunization activities.2,9 
From these inputs we prepared a 
comprehensive list of potential add-on 
interventions. Next, we condensed the 
list based on a review of the evidence of 
the feasibility of interventions, matched 
to target population and effectiveness, 
in the context of a supplementary 
immunization activity.3 Finally, three 
experts engaged with India’s immuni-
zation programme at central and state 
levels prioritized the interventions to 
create a shortlist of interventions for 
analysis based on criteria of program-
matic and technical feasibility and 
policy relevance (Table 1). A total of 
six interventions – generally offered 
in India through the routine health 
system – were selected: (i) nutritional 
screening of children linked to services 
for complementary feeding; (ii) vita-
min A supplementation for children; 
(iii) preventive zinc supplementation 
for children; (iv) free distribution of 
insecticide-treated bednets; (v) mul-
tiple micronutrient supplementation 
for pregnant women (iron, folic acid, 
vitamin A); and (vi) calcium supple-
mentation for pregnant women.
Decision modelling
We modelled the impact of the interven-
tions on maternal and child mortality 
over the period 2009–2013 using the 
freely available Lives Saved Tool (LiST), 
version 4.7 (Johns Hopkins Bloomberg 
School of Public Health, Baltimore, 
United States of America). LiST is a 
mathematical model that synthesizes 
evidence on the causes of maternal and 
child mortality and the effectiveness of 
interventions to combat them.18 The 
structure of the model has been de-
scribed elsewhere.19 LiST can be used 
to project the impact that multiple in-
terventions may have on survival. LiST 
was chosen because its target popula-
tions are similar to those of India’s 
measles supplementary immunization 
activities. In addition, validation studies 
comparing actual measured mortality 
with modelled mortality showed that 
LiST provided accurate predictions in 




Of the 14 states targeted for supple-
mentary immunization, two were 
excluded from our analysis, as data on 
health services coverage (Nagaland, 
population 1 978 502)8 and population 
structure (Arunachal Pradesh, popu-
lation 1 383 727)8 required for model 
parameterization were unavailable. LiST 
developers have made available param-
eterized models representing India and 
the state of Bihar in 2008 and we created 
LiST models for 11 additional supple-
mentary immunization activity states 
by tailoring the Indian LiST module.
We used recent demographic pro-
jections for India to create age- and 
sex-structured populations for model-
ling.10 Estimates for the effectiveness 
of add-on interventions were taken 
from the child health epidemiology 
reference group (CHERG) systematic 
reviews incorporated in LiST, with the 
exception of vitamin A supplementation 
for which we used a more recent meta-
analysis incorporating findings from the 
Deworming and Enhanced Vitamin A 
Trial (DEVTA) in Uttar Pradesh, India.21 
We developed state-specific propor-
tional mortality estimates by mapping 
cause-of-death data from India’s Million 
Deaths Study (MDS)22,23 to the LiST 
model categories. The MDS is a nation-
ally representative longitudinal study of 
premature mortality monitoring 14 mil-
lion people in India, which assigns cause 
of death by physician-reviewed verbal 
autopsy. For Manipur, Meghalaya and 
Tripura, state-specific mortality data 
were not available and for these states 
we used regional proportional mortal-
ity estimates. The MDS did not evaluate 
pertussis deaths as a separate category 
due to the difficulty of distinguishing 
pertussis from causes of death such as 
pneumonia when using verbal autopsy 
techniques. We imputed pertussis deaths 
using CHERG methods.24,25 To charac-
terize immunization coverage before the 
supplementary immunization activity, 
values for other parameters were de-
rived from Indian household surveys. 
The principal data source was India’s 
2007–2008 district level household and 
facility survey;26 data were collected 
just before the measles supplementary 
immunization. The technical appendix 
with illustrations of parameter values 
and data sources for a sample state are 
available from the corresponding author. 
Coverage data for the 2010–2013 mea-
sles supplementary immunization were 
provided by the Government of India.
Integrated vaccination campaign package
We modelled the supplementary immu-
nization activity as occurring in all states 
in a single year (2010). The campaign 
would confer a one-time increase in 
measles vaccination coverage. Some of 
the hypothetical interventions, such as 
delivering vitamin A supplements and 
carrying out nutritional screening, could 
be completed at the time of vaccination. 
For these interventions, increases in 
coverage were modelled as a function 
of measles-containing vaccine coverage 
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achieved by the supplementary immu-
nization. Vitamin A supplements for 
children should be given twice per year; 
a single dose of vitamin A represents 
half the annual recommended dose. 
We therefore calculated the increase 
in vitamin A coverage conferred by 
the supplementary immunization as: 
achieved coverage divided by 2. Nutri-
tional screening is effective only when 
linked to programmes and services. 
Based on expert opinion, we assumed 
that 90% of children screened and 
found nutritionally deficient would be 
linked to follow-up services, including 
complementary feeding, through pro-
grammes such as India’s integrated child 
development services. Several other 
interventions would require additional 
follow-through to be effective. For three 
interventions (multiple micronutrient 
and calcium supplements for pregnant 
women and preventive zinc for children) 
we modelled the causal chain between 
being offered in the supplementary 
immunization activity and increased 
intervention coverage as depending on 
measles-containing vaccine achieve-
ment and compliance. For these inter-
ventions, we used an average compliance 
scenario of 70% and considered two 
additional scenarios bounding reason-
able ranges of low (50%) and high (90%) 
compliance. We assumed that 73% of 
freely distributed long-lasting insecti-
cide-treated bednets would be used.27 
The analytic assumptions are outlined 
in Table 2 (available at: http://www.who.
int/bulletin/volumes/94/10/15-160044), 
with further details available from the 
corresponding author.
Sensitivity analyses
Additional analyses explored the effect 
of using different sources of data for 
proportional mortality (i.e. comparing 
proportional mortality data for India 
from CHERG and state-specific propor-
tional mortality data from the MDS). We 
also quantified the impact of parameter 
uncertainty related to the effective-
ness of vitamin A supplementation on 
diarrhoea mortality for children aged 
6–59 months. To do this we contrasted 
the DEVTA meta-analysis midpoint 
estimate of 11%21 with the 47% mortality 
benefit incorporated in LiST.18 Finally, 
we developed the Dynamic Measles 
Immunization Calculation Engine, a 
transmission dynamic measles model31 
that enabled us to consider factors not 
captured in LiST, such as age-specific 
Table 1. Appraisal of potential add-on interventions for supplementary immunization 
activities in India
Intervention Feasible 













Nutritional screening Yes Yes Likely Selecteda
Vitamin A 
supplementation
Yes Yes Yes Selecteda
Promotion of oral 
rehydration salts or 
therapy
Yes Yes Uncertain Recommendedb
Free distribution of oral 
rehydration salts
Yes Yes Uncertain Recommendedb
Deworming Yes Yes No Recommendedb
Preventive zinc 
supplementation
Yes Yes Uncertain Selecteda
Free distribution of 
insecticide-treated 
bednets
Yes Yes Yes Selecteda
Oral polio vaccine Yes Yes No Recommendedb
DTP vaccine catch-up/
booster dose
Yes Yes Likely Challengingc
Japanese encephalitis 
vaccine
Yes Yes Likely Challengingc
Pneumococcal vaccine Yes Yes Likely Challengingc
Rubella (measles–rubella) 
vaccine
Yes Yes Likely Recommendedb




folic acid, vitamin A)
Yes To some 
extent
Yes Selecteda
Calcium supplementation Yes To some 
extent
Yes Selecteda
Deworming Yes To some 
extent
No Recommendedb










Family planning No Yes Uncertain Potentially 
valuablee
Screening for unmet needs 
and health service referrals
Yes Yes Likely Recommendedb
SIA: supplementary immunization activity; DTP: diphtheria–tetanus–pertussis.
a  Interventions selected for modelling in this analysis.
b  Interventions recommended as appropriate but lower priority for this analysis due to low impact on 
mortality or lack of evidence.
c  With the exception of combination vaccines, offering additional vaccines was viewed as challenging due 
to issues of logistics, safety and human resources.
d  Scope for pregnancy interventions depends on the proportion of children brought by mothers to receive 
measles vaccine and the proportion of pregnant women.
e  Interventions judged to be potentially valuable but lower priority for this analysis due to the need for 
empirical investigation.
Note: Further details of the appraisal are available from the corresponding author.
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vaccine efficacy for measles first and 
second doses, and herd immunity, to 
model the impact on mortality of the 
supplementary immunization activ-
ity delivering only measles-containing 
vaccine.
Equity impact
Equity analyses were done on a state-by-
state basis and assumed that increases in 
supplementary immunization coverage 
reached both sexes equally. To quantify 
the impact of the mass vaccination cam-
paign on sex differences in child mortal-
ity, we used sex-specific proportional 
mortality data from the MDS22 and 
sex-specific coverage data from the third 
round of the district level household 
and facility survey26 and other sources 
(further details are available from the 
corresponding author). We assessed the 
impact on gender equity of the campaign 
delivering measles vaccine only and the 
hypothetical campaign delivering mea-
sles vaccine and add-on interventions by 
comparing the proportion of hypotheti-
cal lives saved by the campaign for girls 
versus boys, and the under-5 mortality 
rate per 1000 live births for girls versus 
boys in the years before (2009) and after 
(2010) the measles campaign.
Results
Overall results
India’s decision to introduce a second 
opportunity for measles vaccination 
via mass vaccination campaign saved 
the lives of an estimated 19 016 under-5 
children in the 12 states included in our 
analysis, of whom 11 121 (58%) were in 
the state of Uttar Pradesh (Table 3).
Table 4 shows the projected lives 
saved in these states by a hypothetical 
supplementary immunization pack-
age that included measles vaccine and 
high-impact add-on interventions for 
children and pregnant women. This was 
based on a scenario of 70% compliance 
with interventions (when applicable) 
and on mortality data from India’s MDS. 
Maternal lives saved were due to calcium 
supplementation in pregnancy; all other 
lives saved represented under-5 chil-
dren. Summing over all states, including 
maternal and child health interventions 
in the measles supplementary immu-
nization campaign would have saved 
around 73 900 (range: 70 200–79 300), 
preventing 73 700 child deaths (range: 
70 000–79 900) and 300 maternal deaths 
(range: 200–400). The hypothetical cam-
paign offering measles vaccine with add-
on interventions was therefore projected 
to increase the number of lives saved 
by a factor of 3.89 (range: 3.69 to 4.17) 
compared with offering measles vac-
cine alone. The benefits of the add-ons 
were also distributed among states more 
closely to the proportion of the popula-
tion (Table 3 and Table 4; supplementary 
data are available from the correspond-
ing author). For example, Uttar Pradesh, 
which had 30.7% of the under-5 target 
population for the supplementary im-
munization, gained 58.5% of lives saved 
from the measles-only supplementary 
immunization (Table 3) and 36.0% of 
lives saved from the package of measles 
supplementary immunization with add-
ons (Table 4).
We explored which add-on inter-
ventions in the whole package contrib-
uted most to the anticipated reductions 
in mortality (Table 4). Summing over 
all states for the average (70%) com-
pliance scenario, the effectiveness of 
the interventions in descending or-
der were: insecticide-treated bednets 
(24 933 lives saved), measles vaccine 
(18 235), preventive zinc supplementa-
tion (15 529), complementary feeding 
(4284), vitamin A supplementation 
(2093), multiple micronutrients supple-
mentation during pregnancy (3761) 
and calcium supplementation during 
pregnancy (271). Some of the lives saved 
by the supplementary immunization 
with add-ons could not be attributed to 
specific interventions and are presented 
instead by syndrome, including diar-
rhoea (1838 lives saved), pneumonia 
Table 2. Assumptions used in the analysis of measles vaccine with a package of six add-
on interventions for the supplementary immunization activity in India
Assumption Value Source
Efficacy of measles vaccine in reducing 
measles mortality
0.85 Published study18
Duration of benefit conferred by SIA 
interventions
Insecticide-treated bednets 3 years Published study28
Measles vaccine Lifelong (beyond analysis 
timeframe)
Published study29
All other interventionsa < 1 year Published study18
Proportion of individuals likely to use 
SIA add-on interventions
Insecticide-treated bednets 73% Published study27
Multiple micronutrient supplements for 
pregnant women
70% compliance (50% 
low; 90% high)b
Expert opinion and 
field data
Calcium supplements for pregnant 
women
70% compliance (50% 
low; 90% high)b
Expert opinion and 
field data
Preventive zinc for children 70% compliance (50% 
low; 90% high)b
Expert opinion
Proportion of children identified 
in the SIA as having nutritional 
deficiencies and linked to services 
for complementary feeding and 
supplementation
90%c Expert opinion
Proportion of pregnant women 
reached by the SIA
Varies by state, range 
21% to 52%
Calculated
Increase in vitamin A coverage 
achieved through the SIA
SIA coverage divided 
by 2d
Calculated
SIA reaches male and female children 
equally
– Published study30
SIA does not reduce coverage of 
routine services
– Assumed
SIA: supplementary immunization activity.
a  This category comprises nutritional screening; vitamin A supplementation for children; preventive zinc 
supplementation for children; multiple micronutrient supplementation in pregnant women (iron, folic 
acid, vitamin A); and calcium supplementation in pregnant women.
b  Further details of compliance scenarios are available from the corresponding author.
c  This estimate for linkage to services is based on the mandate and capacity of India’s integrated child 
development services programme.
d  As Vitamin A supplements should be given twice per year, this represents half an annual dose.
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(2027) and measles (958). Applying the 
low (50%) compliance scenario over all 
states resulted in the same ranking of 
interventions, while for the high (90%) 
compliance scenario, the interventions 
in descending order of importance were: 
bednets, zinc, measles vaccine, multiple 
micronutrients, complementary feeding, 
vitamin A and calcium. 
The contribution to mortality re-
duction of specific interventions varied 
considerably among states, reflecting 
differences in local epidemiology and 
coverage of health services before the 
measles vaccination campaign. For the 
average compliance scenario, measles 
vaccine conferred 3% of the anticipated 
benefit in Chhattisgarh (i.e. 76/2465 
lives saved) and 40% in Uttar Pradesh 
(10 671/26 460); insecticide-treated 
bednets conferred 17% of the benefit in 
Uttar Pradesh (4539/26 460) and 69% 
in Chhattisgarh (1691/2465); while zinc 
conferred 12% of the benefit in Chhat-
tisgarh (301/2465) and 28% (677/2381) 
in Gujarat (Table 4).
Sensitivity analyses
Using different assumptions about pro-
portional mortality affected the findings 
shown in Table 4. Proportional mortal-
ity based on the MDS data attributed 
greater importance to malaria deaths 
and hence a higher projected number 
of lives saved by insecticide-treated bed-
nets (24 933/73 929 lives saved across all 
states) than did proportional mortality 
based on the CHERG data (4591/69 912 
lives saved). Uncertainty concerning 
the effectiveness of vitamin A supple-
mentation in reducing diarrhoea deaths 
among children aged 6–59 months had 
an important impact; higher CHERG 
values appreciably increased the project-
ed lives saved due to administration of 
vitamin A (6637/77 979) compared with 
the DEVTA trial values (2093/73 929). 
A dynamic model replicating India’s 
2010–2013 measles supplementary 
immunization activity projected that a 
one-time supplementary immunization 
delivering only measles-containing vac-
cine would have saved 47 625 to 95 249 
lives of under-5 children, assuming a 
case-fatality ratio of 1–2%.6,32
Equity analyses
The campaign mitigated pre-existing 
inequalities in mortality between girls 
and boys. For under-5 children, the 
supplementary immunization deliver-
ing only measles-containing vaccine 
were projected to save the lives of 12 712 
(66%) girls and 6 635 (34%) boys. The 
hypothetical campaign delivering mea-
sles vaccine and add-on interventions, 
based on the 70% compliance scenario, 
saved an expected 45 721 (62%) girls and 
28 647 (39%) boys (Table 5; additional 
supplementary data are available from 
the corresponding author). For the 
eight states in which under-5 mortality 
per 1000 live births was initially greater 
in girls than in boys, the gender dispar-
ity was reduced by the supplementary 
immunization activity offering measles-
containing vaccine only and further 
reduced by the hypothetical campaign 
delivering measles vaccine and add-on 
interventions (Table 6).
Discussion
Measles vaccination is important for 
reduction of child mortality, yet global 
coverage of the first dose of measles-
containing vaccine has been stagnant 
since 2009.1 Mass vaccination cam-
paigns are resource-intensive and plan-
ners must assess their value among a 
range of options for health improvement 
and resource expenditure. Our analysis 
demonstrated that India’s introduction 
of a second opportunity for measles vac-
cination through large-scale campaigns 
from 2010 to 2013 made an important 
contribution to reducing mortality from 
measles. Our model-based analysis of 
12 of the 14 participating states found 
that India’s measles supplementary 
immunization activity likely saved the 
lives of approximately 19 000 under-5 
children, corresponding to roughly 29% 
(range: 24% to 35%) of India’s annual 
measles mortality.6 We also found that a 
hypothetical supplementary immuniza-
tion package delivering measles vaccine 
and a set of additional interventions of 
known effectiveness would increase the 
impact on mortality of the mass measles 
vaccination campaign more than three-
fold. Despite variation among states, the 
most important interventions in the 
package overall were insecticide-treated 
bednets, measles vaccine and preventive 
zinc supplementation. This reflects the 
high burden of infectious disease and 
undernutrition among Indian children, 
the impact of malaria in some areas and 
the relatively low coverage of these key 
interventions.24–26
Child mortality in India differs 
markedly by sex, with higher mortal-
ity rates recorded for girls.10,22 Care-
giver bias associated with preference 
for a male child likely contributes to 
the mortality differentials due to lower 
use of regular health services for girls. 
Vaccination campaigns, however, show 
a more equal pattern of use.30 We found 
Table 3. Estimated number of under-5 lives saved in 12 states participating in India’s 
2010–2013 measles supplementary immunization activity
State No. (%)
Under-5 lives saved by 
measles vaccine
Under-5 population in SIA statesa
Assam 378 (2.0) 3 556 222 (4.8)
Bihar 3 436 (18.1) 13 811 150 (19.2)
Chhattisgarh 79 (0.4) 3 014 655 (3.8)
Gujarat 262 (1.4) 6 293 984 (8.2)
Haryana 435 (2.3) 2 763 215 (3.6)
Jharkhand 353 (1.9) 4 022 926 (5.5)
Madhya Pradesh 1 864 (9.8) 8 899 016 (11.2)
Manipur 32 (0.2) 257 601 (0.4)
Meghalaya 33 (0.2) 416 638 (0.6)
Rajasthan 996 (5.2) 8 852 191 (11.0)
Tripura 27 (0.1) 339 014 (0.5)
Uttar Pradesh 11 121 (58.5) 24 945 895 (30.7)
All statesb 19 016 (100.0) 77 172 507 (100.0)c
SIA: supplementary immunization activity.
a  Author’s calculations based on Government of India census statistics.8
b  Including all participating states in the 2010–2013 measles SIA.
c  SIA states contained 59% of the under-5 population of India.8
Note: Analyses use proportional mortality from the Million Deaths Study22 and vitamin A effectiveness from 
the Deworming and Enhanced Vitamin A Trial.21 Lives saved were calculated for the period 2010–2013.
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that, due to the high coverage achieved 
in states with weak health systems, 
supplementary immunization helped 
to mitigate gender-related inequities in 
child mortality. We also studied differ-
ences in mortality for subgroups defined 
by household wealth status (quintiles) 
and area of residence (rural/urban). 
However, the results were uninforma-
tive due to the absence of state- and 
stratum-specific proportional mortality 
data (available from the corresponding 
author).
The components of this integrated 
health package for a supplemental 
mass vaccination campaign were de-
signed based on a systematic appraisal 
of the evidence and a quantitative 
projection of likely impact. Add-on 
interventions were systematically se-
lected using the published scientific 
literature and expert guidance.9 A key 
advantage of this approach is that it 
presents the evidence and assump-
tions in a transparent framework that 
permits alternatives to be explored. 
We placed particular emphasis on 
defining options for analysis that were 
evidence-based, feasible and relevant 
to the Indian context. Cause-of-death 
data from India’s MDS22 enabled us to 
show state- and sex-specific mortality 
patterns, while data from recent house-
hold surveys26 facilitated an accurate 
portrayal of health services coverage. 
LiST is a validated policy model that 
enables competing mortality risks to be 
considered.19 In addition, we validated 
the LiST projections of the impact of 
measles-containing vaccine using a 
transmission dynamic model that takes 
into account both herd immunity and 
age-specific vaccine efficacy. As antici-
pated, the dynamic model results were 
consistent with LiST results but showed 
a somewhat higher impact on mortality 
for the supplementary immunization 
with measles vaccine.
We highlight five limitations of 
the analysis. First, the LiST model 
focuses only on mortality. Many of 
the add-on interventions studied also 
reduce morbidity, and some potentially 
important interventions, such as anti-
helminthic drugs, were not considered 
as their direct impact is exclusively 
on morbidity.2 Second, limited avail-
ability of data forced us to exclude two 
states of less than 2 million inhabitants 
each.3,8 Third, uncertainty concerning 
parameter values for vitamin A effec-
tiveness, proportional mortality due to 
malaria, and compliance were found to 
influence mortality projections.4 Fourth, 
our mortality projections represent a 
specific point in time, whereas child 
survival and health services coverage 
are changing rapidly in India.5 Finally, 
due to constraints of logistics, it may 
not be possible in practice to offer as 
many add-on interventions as we have 
modelled for this analysis. Our pri-
mary purpose was to demonstrate the 
potential benefits of bundling proven 
interventions with a vaccination cam-
paign. We also showed the utility of an 
evidence-based approach for planning 
add-ons for supplementary immuniza-
Table 4. Projected number of lives saved due to a hypothetical package of measles vaccine with a set of additional maternal and child 
health interventions during the measles supplementary immunization activity, India 2010–2013
Compliance 
scenario and state
No. of lives saved














By state (70% 
scenario)
Assam 365 3 611 810 254 149 131 16 121 93 31 5 581
Bihar 3 265 3 981 3 030 1 076 595 415 43 417 421 169 13 412
Chhattisgarh 76 1 691 301 123 126 41 10 33 56 8 2 465
Gujarat 256 733 677 156 250 107 11 63 75 53 2 381
Haryana 421 374 246 61 122 50 5 23 19 15 1 336
Jharkhand 338 2 945 773 192 172 101 13 92 100 24 4 750
Madhya Pradesh 1 791 4 240 2 163 532 499 264 28 234 301 97 10 149
Manipur 31 177 62 42 12 8 1 46 53 35 467
Meghalaya 32 180 82 9 14 10 1 48 56 35 467
Rajasthan 962 2 256 1 604 268 479 175 34 95 204 41 6 118
Tripura 27 206 69 9 10 10 1 4 6 1 343
Uttar Pradesh 10 671 4 539 5 712 1 562 1 333 781 108 662 643 449 26 460
All states
70% scenario 18 235 24 933 15 529 4 284 3 761 2 093 271 1 838 2 027 958 73 929
50% scenario 18 314 24 929 13 346 4 292 2 687 2 109 196 1 647 1 806 829 70 155
90% scenario 18 159 24 934 19 849 4 235 4 838 2 080 350 1 870 2 061 945 79 321
a  Lives saved due to the intervention listed in the column header.
b  These are maternal deaths; all other deaths represent children younger than 5 years.
c  Additional lives saved due to prevention of disease (not intervention-specific).
Note: Including 12 states participating in India’s 2010–2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths 
Study22 and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.21 Lives saved were calculated for the period 2010–2013. Compliance figures 
apply to multiple micronutrients and calcium for pregnant women, and preventive zinc for children; compliance scenarios are outlined in Table 2.
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Table 5. Projected number of lives saved for under-5 children due to measles vaccine only or due to a hypothetical package of measles 
vaccine with a set of additional maternal and child health interventions during the measles supplementary immunization 
activity, India 2010–2013, by child’s sex
State Lives saved by measles vaccine only Lives saved by measles vaccine with add-on interventionsa
Total, no. Girls, no. (%) Boys, no. (%) Total, no. Girls, no. (%) Boys, no. (%)
Assam 379 242 (64) 138 (36) 5 579 3 090 (55) 2489 (45)
Bihar 3 439 2 231 (65) 1 209 (35) 13 373 8 456 (63) 4 917 (37)
Chhattisgarh 77 34 (45) 42 (55) 2 438 1 169 (48) 1 270 (52)
Gujarat 299 200 (67) 99 (33) 2 396 1 397 (58) 999 (42)
Haryana 430 269 (62) 161 (38) 1 334 850 (64) 484 (36)
Jharkhand 355 225 (63) 130 (37) 4 695 2 493 (53) 2 202 (47)
Madhya Pradesh 1 899 999 (53) 900 (47) 10 379 5 730 (55) 4 649 (45)
Manipur 32 14 (45) 18 (55) 329 158 (48) 171 (52)
Meghalaya 33 15 (46) 18 (54) 337 164 (49) 173 (51)
Rajasthan 1 080 831 (77) 249 (23) 6 292 4 268 (68) 2 024 (32)
Tripura 27 13 (49) 14 (51) 376 199 (53) 176 (47)
Uttar Pradesh 11 296 7 639 (68) 3 657 (32) 26 839 17 747 (66) 9 093 (34)
Totalb 19 346 12 712 (66) 6 635 (34) 74 367 45 721 (61) 28 647 (39)
a  Add-on interventions were nutritional screening linked to complementary feeding; vitamin A supplementation for children; preventive zinc supplementation for 
children; free distribution of insecticide-treated bednets; multiple micronutrient supplementation in pregnant women (iron, folic acid, vitamin A); and calcium 
supplementation in pregnant women.
b  State totals represent the sum of sex-specific models and thus differ from Table 3.
Note: Including 12 states participating in India’s 2010–2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths 
study22 and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.21 Lives saved were calculated for the period 2010–2013. Data are based on the 
70% compliance scenario (see Table 2) and apply to multiple micronutrients and calcium during pregnancy, and preventive zinc for children.
Table 6. Projected under-5 mortality in the years before (2009) and after (2010) the measles supplementary immunization activity, 
India 2010–2013, by child’s sex
State Measles vaccine only Measles vaccine with add-on interventionsa
Deaths per 1000 live births Difference 
(2010–2009)b
Deaths per 1000 live births Difference 
(2010–2009)b
Girls Boys Girls Boys Girls Boys Girls Boys
2009 2010 2009 2010 2009 2010 2009 2010
Assam 87.0 86.4 79.0 78.7 −0.6 −0.3 87.9 83.4 79.9 76.3 −4.5 −3.6
Bihar 68.0 66.3 60.0 59.0 −1.7 −1.0 68.3 63.3 60.3 57.4 −5.0 −2.9
Chhattisgarh 61.0 60.9 61.0 60.9 −0.1 −0.1 62.2 59.8 62.2 59.9 −2.4 −2.3
Gujarat 60.0 59.7 52.0 51.9 −0.3 −0.1 60.5 58.9 52.5 51.4 −1.6 −1.1
Haryana 59.0 58.0 50.5 51.0 −1.0 0.5 60.2 57.5 52.2 50.7 −2.7 −1.5
Jharkhand 59.0 58.2 59.0 58.7 −0.8 −0.3 59.9 56.1 59.9 56.7 −3.8 −3.2
Madhya 
Pradesh
85.0 83.9 82.0 81.0 −1.1 −1.0 85.4 81.0 82.4 78.9 −4.4 −3.5
Manipur 79.0 78.5 79.0 78.3 −0.5 −0.7 89.5 87.7 89.5 87.5 −1.8 −2.0
Meghalaya 79.0 78.6 79.0 78.5 −0.4 −0.5 89.8 88.0 89.8 87.8 −1.9 −2.0
Rajasthan 79.0 78.0 60.0 59.7 −1.0 −0.3 79.5 75.7 60.5 58.7 −3.8 −1.8
Tripura 79.0 78.6 79.0 78.6 −0.4 −0.4 87.2 84.6 87.2 85.0 −2.6 −2.2
Uttar Pradesh 87.0 83.8 71.0 69.5 −3.2 −1.5 87.2 81.1 71.2 68.1 −6.1 −3.1
a  Add-on interventions were nutritional screening linked to complementary feeding; vitamin A supplementation for children; preventive zinc supplementation for 
children; free distribution of insecticide-treated bednets; multiple micronutrient supplementation in pregnant women (iron, folic acid, vitamin A); and calcium 
supplementation in pregnant women.
b  Results were calculated without applying background trends in acquired immune deficiency syndrome mortality.
Note: Including 12 states participating in India’s 2010–2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths 
Study22 and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.21 Lives saved were calculated for the period 2010–2013.
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tion activities. The integrated package 
studied in this analysis should be seen 
as aspirational. In practice, the impact 
on mortality will depend on the actual 
interventions offered and may be less 
than illustrated here.
Mass measles vaccination cam-
paigns in many countries have offered 
additional interventions,2 but the choice 
of which interventions to include has 
generally been made in an ad hoc 
way rather than through a systematic 
analysis such as the one illustrated here. 
Although the interventions we exam-
ined were all deemed by Indian health 
planners to be technically feasible to 
incorporate into mass vaccination 
campaigns, implementation research 
is needed to assess the feasibility and 
impact on health systems of offering 
these interventions. We also need to 
assess the cost–effectiveness of supple-
mentary immunization activities that 
include measles vaccine and add-on 
maternal and child health interventions 
in India. As vaccination campaigns must 
be repeated periodically, this research 
has the potential to revitalize political 
support for accelerated measles control 
strategies, as well as for other vaccines 
delivered through mass campaigns, such 
as rubella and polio. ■
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صخلم
دنلها في ةبصلحا دض ةيعمالجا تمايعطتلا لىإ تلاخدتلا ةفاضإ
 ةعوممج ميدقت نم تايفولا لدعم لىع يرثأتلا ىدم سايق ضرغلا
 ةينفلا  ةيحانلا  نم  ةنكملماو  يرثأتلا  ةيلاع  تلاخدتلا  نم  ةيضاترفا
 تايلاعف  ءانثأ  ةايلحا  ديق  لىع  لافطلأاو  تاهملأا  ءاقب  تلادعلم
 ماع  نم  ةترفلا  في  دنلها  في  ةماقلما  ةبصلحا  دض  لييمكتلا  ينصحتلا
.2013 ماع لىإ 2010
 ددعل ”Lives Saved Tool“ ةادأ جذمان دادعإب انمق دقل ةقيرطلا
 اًدانتسا  ،لييمكتلا  ينصحتلا  تايلاعف  في ةكراشم ةيدنه ةيلاو 12
 نم  عونلاو  ةيلاولا  بسحب  تايفولا  لدعمب  ةصالخا  تانايبلا  لىإ
 نم ةيحصلا تامدلخا ةيطغت لوحو دنلها في ةافو ةلاح نويلم ةسارد
 ةيفاضلإا  تلاخدتلا  ضعب ديدتح مت  .ةيدنلها  ةيسرلأا تاحوسلما
 دقل .ءابرلخا عم رواشتلاو تاباتكلا ضارعتسا للاخ نم ةلمتحلما
 ةيميعطت  ةلملح ةبسنلاب  اهذاقنإ  مت  يتلا  حاورلأا  ددع سايقب  انمق
 دض ميعطتلا  ةيميعطت ةلحم لباقم طقف ةبصلحا دض ميعطتلا  رفوت
 ةيذغتلاو يئاذغلا ماظنلا صحف( ةيفاضإ تلاخدت ةتس عم ةبصلحا
 أ  ينماتيفو  كنزلا  نم  ةيئاذغلا  تلامكلماو  ،لافطلأل  ةيليمكتلا
 نم  ةيئاذغلا  تلامكلماو  ةقيقدلا  تايذغلما  نم  ديدعلاو  ،لافطلأل
 ةداضلما تايسومانلل نياجلما عيزوتلاو لملحا ةلحرم في مويسلاكلا
.)تاشرحلل
 برقي ام ةايح ذاقنإ في ةبصلحا دض ميعطتلا ةلحم تهماس دقل جئاتنلا
 مهاست نأ عقوتلما نم ناكو .ماوعأ 5 نم رغصأ ًلافط 19016 نم
 عم ةبصلحا دض ميعطتلا لمشت يتلا ةيضاترفلاا ةيميعطتلا ةلملحا
 اًصخش 73900  نم برقي ام ةايح ذاقنإ في ةيفاضلإا تلاخدتلا
 73700  ثودح  عنمو  ،)79300  لىإ  70200  :ىدلما  لىع(
 300و  )79000  لىإ  70000  :ىدلما  لىع(  لافطلأل  ةافو  ةلاح
 رثكأ  تناكو  .)400  لىإ  200  :ىدلما  لىع(  تاهملأل  ةافو  ةلاح
 ةداضلما  تايسومانلا  يه  اهلمكأب  ةمزلحا  في  ةيلاعف  تلاخدتلا
 .كنزلا نم ةيئاذغلا تلامكلماو ةبصلحا دض ميعطتلاو ،تاشرحلل
 66% ةبسنب اهذاقنإ مت يتلا حاورلأا لدعم يرسفتب تايتفلا تماقو
 ،ةبصلحا  دض  ةيميعطتلا  ةلمحلل  ةجيتن  )19346/12712(
 )74367/45721( 62% ةبسنب اهذاقنإ مت يتلا حاورلأا لدعمو
 تلاخدتلا  لمشت  يتلا  ةيضاترفلاا  ةيميعطتلا  ةلمحلل  ةجيتن
 .ةيفاضلإا
 لمشت  ةبصلحا  دض  ةيميعطت  ةلملح  نكمي  ،دنلها  في  جاتنتسلاا
 لكشب  مهاست  نأ  عفترم  يرثأت  تاذو  اهؤارجإ  نكمي  تلاخدت
 تلااح نم فيفختلاو اهذاقنإ متي يتلا حاورلأا ددع ةدايز في يربك
.لافطلأا تايفو في عونلاب ةطبترلما توافتلا
摘要
印度大规模麻疹免疫接种活动的干预措施













结果 据估计 , 该麻疹疫苗活动拯救了 19 016 位 5 岁以
下儿童的生命。 一项配有附加干预措施的假设性麻
疹疫苗活动预计将拯救大约 73 900 人的生命 ( 范围 : 
70 200–79 300), 使 73 700 位儿童 ( 范围 : 70 000–79 000)
和 300 位母亲免于死亡 ( 范围 : 200–400)。 整个系列
中效果最好的干预措施为经杀虫剂处理的蚊帐、麻疹
疫苗和预防性锌补充。在麻疹疫苗活动中预计拯救的
生命数中 , 女孩占 66% (12 712/19 346), 其中 62% 被拯
救生命 (45 721/74 367) 归因于配有附加干预措施的假
设性活动。
结论 在印度 , 配有可行的高影响力干预措施的麻疹疫
苗活动可大大增加被挽救生命数 , 并缓和导致儿童死
亡率的性别不平等。
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Résumé
Ajout d’interventions aux vaccinations de masse contre la rougeole en Inde
Objectif Quantifier l’impact sur la mortalité d’un hypothétique 
ensemble d’interventions à fort impact et techniquement réalisables 
pour la survie de la mère et de l’enfant lors d’une activité de vaccination 
antirougeoleuse supplémentaire menée en Inde de 2010 à 2013.
Méthodes Pour 12 des États indiens participant à l’activité de 
vaccination supplémentaire, nous avons élaboré des modèles LiST (Lives 
Saved Tool – Outil de Vies Sauvées) en fonction de données ventilées par 
État et par sexe sur la mortalité – tirées de l’étude indienne Million Deaths 
Study –, et sur la couverture des services de santé – tirées d’enquêtes 
auprès des ménages indiens. Des interventions supplémentaires 
potentielles ont été identifiées à l’aide d’un examen de la littérature et de 
consultations d’experts. Nous avons quantifié le nombre de vies sauvées 
dans le cadre d’une campagne de vaccination antirougeoleuse seule par 
rapport à une campagne de vaccination antirougeoleuse comportant 
six interventions supplémentaires (analyse nutritionnelle et alimentation 
d’appoint pour les enfants, supplémentation en vitamine A et en zinc 
pour les enfants, supplémentation en micronutriments multiples et en 
calcium au cours de la grossesse et distribution gratuite de moustiquaires 
imprégnées d’insecticide).
Résultats D’après nos estimations, la campagne de vaccination 
antirougeoleuse a permis de sauver 19 016 enfants âgés de moins de 
5 ans. Il a été calculé qu’une hypothétique campagne de vaccination 
antirougeoleuse incluant des interventions supplémentaires permet 
de sauver quelque 73 900 vies (étendue: 70 200–79 300), prévenant 
le décès de 73 700 enfants (étendue: 70 000–79 000) et de 300 mères 
(étendue: 200–400). Les interventions les plus efficaces se sont avérées 
être les moustiquaires imprégnées, le vaccin contre la rougeole et la 
supplémentation préventive en zinc. Les filles représentaient 66% des 
vies sauvées escomptées (12 712/19 346) dans le cadre de la campagne 
de vaccination antirougeoleuse et 62% des vies sauvées (45 721/74 367) 
dans le cadre de la campagne hypothétique incluant des interventions 
supplémentaires.
Conclusion En Inde, une campagne de vaccination antirougeoleuse 
comportant des interventions réalisables à fort impact pourrait 
considérablement accroître le nombre de vies sauvées et réduire les 
inégalités entre les sexes concernant la mortalité infantile.
Резюме
Вмешательства, дополняющие массовую вакцинацию против кори в Индии
Цель Оценить, в какой степени предложение гипотетического 
набора технически исполнимых вмешательств с высоким 
уровнем воздействия для повышения выживаемости среди 
матерей и детей могло повлиять на уровни смертности в 
ходе дополнительного мероприятия по противокоревой 
иммунизации, проводимого в Индии в 2010–2013 гг.
Методы Были разработаны модели Инструмента спасенных 
жизней (Lives Saved Tool) для 12 штатов Индии, участвующих в 
дополнительной иммунизации, при этом исследователи исходили 
из конкретных данных о смертности, взятых из исследования 
«Миллион смертей» (Million Deaths Study) в Индии с разбивкой 
по штатам и половому признаку, а также из данных об охвате 
населения Индии службами здравоохранения, полученных 
путем анкетирования семей. Потенциальные дополнительные 
вмешательства были определены путем изучения литературных 
данных и консультирования со специалистами. Количество 
жизней, которые были спасены в ходе кампании, предлагающей 
только противокоревую вакцинацию, подсчитали и сравнили 
с количеством жизней, которые можно было бы спасти в ходе 
кампании, в которой противокоревая вакцина сочеталась бы с 
шестью дополнительными вмешательствами (скрининг питания и 
прикорм детей, введение в детский рацион добавок, содержащих 
витамин А и цинк, прием беременными множественных 
добавок, содержащих питательные микроэлементы и кальций, 
и бесплатное распространение кроватных сеток, обработанных 
инсектицидами).
Результаты Вакцинация против кори позволила спасти от 
смерти примерно 19  016 детей в возрасте младше пяти лет. 
Гипотетическая кампания, в которой, помимо противокоревой 
вакцины, применялись бы еще дополнительные вмешательства, 
согласно прогнозам, могла бы спасти около 73  900 жизней 
(диапазон полученных оценок от 70 200 до 79  300 человек), из 
которых в 73  700 случаях была бы предотвращена смерть детей 
(диапазон значений от 70 000 до 79  000 человек) и в  300 случаях 
— смерть матерей (диапазон значений от 200 до  400 человек). 
Из всего набора вмешательств наиболее эффективными 
оказались бы кроватные сетки, обработанные инсектицидами, 
противокоревая вакцина и профилактическое употребление 
цинксодержащих добавок. Из числа всех предположительно 
спасенных детей девочки составили 66% (12 712 из 19  346 детей) 
в случае противокоревой вакцинации, а для предполагаемой 
кампании с дополнительными вмешательствами их доля 
составила бы 62% (45  721 ребенок из 74 367).
Вывод В условиях Индии кампания вакцинации против 
кори, включающая реалистичные и высокоэффективные 
дополнительные вмешательства, способна значительно 
увеличить количество спасенных детей и сгладить гендерные 
различия в показателях детской смертности.
Resumen
Adición de intervenciones a las vacunaciones antisarampionosas en masa en la India
Objetivo Cuantificar el impacto en la mortalidad del hecho de ofrecer 
un conjunto hipotético de intervenciones técnicamente viables y de alto 
impacto para la supervivencia de madres e hijos durante la actividad 
de inmunización suplementaria antisarampionosa en la India entre 
2010 y 2013.
Métodos Se desarrollaron los modelos de la herramienta “Live 
Saved Tool” para 12 estados indios participantes en la inmunización 
suplementaria, en base a información según el estado y el sexo sobre 
la mortalidad recopilada en el estudio “Million Deaths Study” de la India 
y sobre la cobertura de servicios sanitarios de las encuestas domésticas 
realizadas en la India. Se identificaron posibles intervenciones adicionales 
a través de un análisis de documentos y consultas a expertos. Se 
cuantificó el número de vidas salvadas durante una campaña que 
ofrecía la vacuna antisarampionosa frente a una campaña que ofrecía la 
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vacuna antisarampionosa con seis intervenciones adicionales (revisión 
nutricional y alimentación complementaria para niños, suplementos 
de vitamina A y zinc para niños, varios micronutrientes, suplemento 
de calcio durante el embarazo y distribución gratuita de mosquiteros 
tratados con insecticida).
Resultados La campaña de vacunación antisarampionosa salvó unas 
19 016 vidas de niños menores de 5 años. Se estimó que una campaña 
hipotética que incluía la vacuna antisarampionosa e intervenciones 
adicionales salvaría unas 73 900 vidas (alcance: 70 200–79 300), 
evitando 73 700 muertes infantiles (alcance: 70 000–79 000) y 300 
muertes maternas (alcance: 200–400). Las intervenciones más eficaces 
de todo el paquete fueron los mosquiteros tratados con insecticida, 
la vacuna antisarampionosa y el suplemento preventivo de zinc. Las 
niñas representaron un 66% de las vidas salvadas (12 712/19 346) 
durante la campaña de vacuna antisarampionosa y un 62% de las vidas 
salvadas (45 721/74 367) durante la campaña hipotética que incluye las 
intervenciones adicionales.
Conclusión En la India, una campaña de vacunación antisarampionosa 
que incluya intervenciones viables y de gran impacto podría incrementar 
enormemente el número de vidas salvadas y mitigar la desigualdad de 
género en la mortalidad infantil.
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